G. R. Tennvall

发表

Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study

M. Huijberts, M. Edmonds, D. Mauricio, 2008, Diabetologia.

The economic costs of acute myeloid leukemia in Sweden.

U. Persson, G. R. Tennvall, B. Nilsson, 1994, International journal of technology assessment in health care.

Counting the costs Counting the costs of the diabetic foot

J. Apelqvist, G. R. Tennvall, 2005 .

TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study

L. Cardell, P. Olsson, J. Hellgren, 2016, npj Primary Care Respiratory Medicine.

Self-treatment with desmopressin intranasal spray in patients with bleeding disorders: Effect on bleeding symptoms and socioeconomic factors

S. Lethagen, G. R. Tennvall, 1993, Annals of Hematology.

Accurate diagnosis and effective treatment of leg ulcers reduce prevalence, care time and costs.

G. R. Tennvall, Oien Rf, 2006 .

Indirect costs related to caregivers’ absence from work after paediatric tonsil surgery

J. Stalfors, J. Hellgren, G. Gudnadottir, 2017, European Archives of Oto-Rhino-Laryngology.

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer

J. Fernberg, G. R. Tennvall, 1998, Medical oncology.

Cost-Effectiveness Analysis of Treatment with Liposomal Amphotericin B versus Conventional Amphotericin B in Organ or Bone Marrow Transplant Recipients with Systemic Mycoses

B. Wettermark, U. Persson, G. Tydén, 1992, PharmacoEconomics.

Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study

M. Huijberts, J. V. van Baal, M. Edmonds, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Cost-effectiveness of mometasone furoate nasal spray in the treatment of acute rhinosinusitis.

P. Stjärne, P. Olsson, J. Lundberg, 2012, Primary care respiratory journal : journal of the General Practice Airways Group.

The Diabetic Foot. Costs, health economic aspects, prevention and quality of life.

G. R. Tennvall, 2000 .

Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis.

Å. Svensson, A. Bergman, J. Hjelmgren, 2011, Acta dermato-venereologica.

J. Norlin, I. Malmberg, G. R. Tennvall, 2015, Health and Quality of Life Outcomes.

Cost Effectiveness of Helicobacter pylori Eradication Therapies in Patients with Duodenal Ulcer

A. Norinder, B. Ohlin, G. R. Tennvall, 1999, PharmacoEconomics (Auckland).

[Treatment of venous leg ulcers can be better and cheaper. Annual costs calculation based on an inquiry study].

M. Bjellerup, J. Hjelmgren, G. R. Tennvall, 2004, Lakartidningen.

Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts

R. Goodall, G. Kinghorn, I. Byren, 2003, Sexually transmitted infections.

Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations

J. Apelqvist, G. Ragnarson Tennvall, G. R. Tennvall, 2001, Diabetologia.

Local Treatment Pattern Versus Trial-based Data: A Cost-effectiveness Analysis of Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis in Sweden

U. Persson, J. Hjelmgren, G. R. Tennvall, 2005, American journal of therapeutics.

High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study

L. Uccioli, H. Reike, M. Huijberts, 2006, Diabetologia.

Optimal Organization of Health Care in Diabetic Foot Disease: Introduction to the Eurodiale Study

Karel Bakker, Didac Mauricio, M. Huijberts, 2007, The international journal of lower extremity wounds.

J. Apelqvist, G. Ragnarson Tennvall, G. R. Tennvall, 2000, Journal of diabetes and its complications.

Importance of factors determining the low health‐related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study

H. Thorsen, M. Edmonds, D. Mauricio, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Cost-effectiveness of Maintenance Treatment with a Barrier-strengthening Moisturizing Cream in Patients with Atopic Dermatitis in Finland, Norway and Sweden.

Å. Svensson, Hanna Norrlid, G. R. Tennvall, 2016, Acta dermato-venereologica.

Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation

M. Huijberts, J. V. van Baal, M. Edmonds, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Original Article: Complications Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study

M. Huijberts, M. Edmonds, D. Mauricio, 2008 .

Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation

M. Spraul, N. Schaper, J. Apelqvist, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Importance of factors determining the low health‐related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study

H. Thorsen, M. Edmonds, A. Jirkovska, 2013, Diabetic medicine : a journal of the British Diabetic Association.

PHL6 TREATMENT OF LEG ULCERS IN SWEDEN STILL DEMANDS LARGE RESOURCES IN SPITE OF IMPROVED MANAGEMENT—THE COST OF ILLNESS (COI) ESTIMATED FROM A PATIENT SURVEY AND PUBLISHED EPIDEMIOLOGICAL STUDIES

J. Hjelmgren, G. R. Tennvall, 2003 .

PHL7 COST OF TREATMENT (COT) FOR VENOUS LEG ULCERS IN SWEDEN AND THE UK—ESTIMATES FROM CLINICAL EXPERT PANELS AND MODEL SIMULATIONS

J. Hjelmgren, G. R. Tennvall, 2003 .

Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts

I. Byren, S. Barton, G. R. Tennvall, 2003, Sexually transmitted infections.